Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2026)
Outset Medical's (OM) quarterly Non-Current Deffered Revenue came in at $302000.0 in Q2 2026, down 48.55% year-over-year from $587000.0 in Q2 2025, and down 17.49% quarter-over-quarter from $366000.0 in Q1 2026.
Powered by 
Analysis
Outset Medical (OM) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Non-Current Deffered Revenue for 8 consecutive years, with $302000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deffered Revenue fell 48.55% year-over-year to $302000.0 in Q2 2026; TTM through Jun 2026 was $302000.0, a 48.55% decrease from a year earlier, with the FY2025 full-year figure at $406000.0, down 51.9% from the prior year.
- Non-Current Deffered Revenue was $302000.0 for Q2 2026 at Outset Medical, down from $366000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $844000.0 in Q4 2024 and troughed at $77000.0 in Q3 2024.
- A 5-year average of $304166.7 and a median of $190000.0 in 2022 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue plunged 63.81% in 2022 and jumped 777.92% in 2025, its largest moves.
- Over 5 years, Non-Current Deffered Revenue stood at $151000.0 in 2022, then tumbled by 33.11% to $101000.0 in 2023, then jumped by 735.64% to $844000.0 in 2024, then sank by 51.9% to $406000.0 in 2025, then fell by 25.62% to $302000.0 in 2026.
- The last three Non-Current Deffered Revenue figures came in at $302000.0 (Q2 2026), $366000.0 (Q1 2026), and $406000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.05 Bn | 174.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.97 Bn | 122.75 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.27 Bn | 108.45 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.98 Bn | 100.50 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.03 Bn | 62.49 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.93 Bn | 31.47 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.26 Bn | 30.31 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Outset Medical | 59.95 Mn | -203.24 Mn | 13.28 Mn | 302,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 302,000.00 |
| Mar 31, 2026 | 366,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 676,000.00 |
| Jun 30, 2025 | 587,000.00 |
| Mar 31, 2025 | 804,000.00 |
| Dec 31, 2024 | 844,000.00 |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 99,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 205,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | 312,000.00 |
| Sep 30, 2021 | 109,000.00 |